Good things are worth waiting for - welcome to the second half of 2022!
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Good things are worth waiting for - welcome to the second half of 2022!

We are finally entering a very exciting period for the company, as we will soon have first patient in our pivotal trial 0205, a trial that will investigate the postoperative analgesic efficacy of CT001.
We obtained regulatory approval by the authorities and thereby green light at the end of June and have since then prepared the site and involved dental clinics. We are ready and hope to announce first patient within a few weeks. This will basically take the company to the next level as not that many companies are in a late-stage clinical development... 

Upcoming top line results of Trial 0206
During this quarter (Q3) we also anticipate to announce the top-line results of trial 0206, the study completed recruitment earlier this year and is currently undergoing statistical analysis.  The trial investigates pharmacokinetics of CT001 in children aged 1-17 undergoing elective surgical procedures. The results will be very important in the work going forward and we are very excited that we soon have the results.

Developing the Team - welcome to Martin, head of CMC & Device
CMC & Device development is instrumental, so we are very fortunate to have Martin joining us earlier this year. Martin has a Ph.D. in Chemistry and a postdoc from Harvard prior to joining Lundbeck where he worked for 14 years, while also obtaining a degree in Pharmaceutical Medicine. He is both as a CMC subject-matter-expert, has 12 years of project management experience & been involved in 15 IMPD/IND submissions.

Entrepreneurship award donated to Rigshospitalet
We donated the prize money we won from the Rotary entrepreneurship award to Rigshospitalet and bought Toy's for the Children - children are often waiting or hospitalised for longer periods and especially if they are frequent visiting due to for instance chronic conditions. On the picture is Laura, and when the picture was taken, she had been anaesthetised for the 37th time at Rigshospitalet. Happy that we can make a small difference….and thanks to the Rotary Club for awarding and selecting us as district winners for our entrepreneurship. 

Bifogade filer

Nyheter om Cessatech

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Cessatech

Senaste nytt